ADAR1 Capital Management »

Organon & Co shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Organon & Co (OGN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Organon & Co

Tip: Access up to 7 years of quarterly data

All positions including Organon & Co held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Organon & Co by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $113k 6.0k 18.80

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Organon & Co

BlackRock
BlackRock
Vanguard Group
Massachusetts Financial Services
State Street Corporation
LSV Asset Management
Nordea Investment Management Ab
Morgan Stanley
Sound Shore Management
Geode Capital Management
Bank of New York Mellon
Citadel Advisors
Charles Schwab Investment Management
Dimensional Fund Advisors
AQR Capital Management

View all funds holding Organon & Co